Share / Export Citation / Email / Print / Text size:

Postępy Mikrobiologii - Advancements of Microbiology

Polish Society of Microbiologists

Subject: Microbiology


ISSN: 0079-4252
eISSN: 2545-3149





Volume / Issue / page

Related articles

VOLUME 57 , ISSUE 4 (April 2018) > List of articles


Beata Podgórska * / Danuta Kędzia

Keywords : healthcare-associated infections, Staphylococcus epidermidis

Citation Information : Postępy Mikrobiologii - Advancements of Microbiology. Volume 57, Issue 4, Pages 348-359, DOI:

License : (CC BY-NC-ND 4.0)

Published Online: 24-May-2019



Healthcare-associated infections and antimicrobial resistance are two of the most important threats in the contemporary medicine, representing a serious burden for the public health system. Previously regarded only as an innocuous commensal microorganism of human skin, S. epidermidis is nowadays seen as an important opportunistic pathogen and the most frequent cause of nosocomial infections. S. epidermidis is the most genetically diverse species within the genus Staphylococcus. Strains belonging to ST2, the most frequently found clonal type of hospital-associated invasive S. epidermidis, are characterized by bacterial biofilm formation and resistance to methicillin, amongst other antibiotics. S. epidermidis is mainly responsible for bloodstream infections and other biomedical device-related infections. Treating infections characterized by biofilm formation is problematic. An additional challenge is differentiation between actual S. epidermidis bloodstream infections and blood probe contamination.

Content not available PDF Share



1. Aanensen D.M., Spratt B.G.: The multilocus sequence typing network: Nucleic Acids Res. 1, DOI: 10.1093/nar/gki415 (2005)

2. Archer G.L.: Molecular epidemiology of multiresistant Staphylococcus epidermidis. J. Antimicrob. Chemother. 21, 133–138 (1988)

3. Asaad A.M., Qureshib M.A., Hasanc S.M.: Clinical significance of coagulase-negative staphylococci isolates from nosocomial bloodstream infections. Infect. Dis. 48, 356–360 (2016)

4. Barbier F., Ruimy R. i wsp.: Methicillin-resistant coagulase-negative staphylococci in the community: high homology of SCCmec IVa between Staphylococcus epidermidis and major clones of methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 15, 270–281 (2010)

5. Bates D.W., Goldman L., Lee T.H.: Contaminant blood cultures and resource utilization. The true consequences of false-positive results. JAMA, 265, 365–369 (1991)

6. Bathoorn E., Hetem D.J., Alphenaar J., Kusters J.G., Bonten M.J. Emergence of high-level mupirocin resistance in coagulase-negative staphylococci associated with increased short-term mupirocin use. J. Clin. Microbiol. 50, 2947–2950 (2012)

7. Bearman G.M., Wenzel R.P.: Bacteremias: a leading cause of death. Arch. Med. Res. 36, 646–659 (2005)

8. Becker K., Heilmann C., Peters G.: Coagulase-negative staphylococci. Clin. Microbiol. Rev. 27, 870–926 (2014)

9. Biavasco, F., Vignaroli, C., Varaldo, P.E.: Glycopeptide resistance in coagulase negative staphylococci. Eur. J. Clin. Microbiol. Infect. Dis. 19, 403–417 (2000)

10. Boghossian N.S., Higgins R.D. i wsp.: Late-onset sepsis invery low birth weight infants from singleton and multiple-gestation births. J. Pediatr. 162, 1120–1124 (2013)

11. Cerca N., Jefferson K.K., Oliveira R., Pier G.B., Azeredo J.: Comparative antibody-mediated phagocytosis of Staphylococcus epidermidis cells grown in a biofilm or in the planktonic state. Infect. Immun. 74, 4849–4855 (2006)

12. Cerca N., Martins S., Cerca F., Jefferson K.K., Pier G.B.,Oliveira R., Azeredo J.: Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry. J. Antimicrob. Chemoth. 56, 331–336 (2005)

13. Cherifi S., Byl B., Deplano A., Nonhoff C., Denis O., Hallin M.: Comparative epidemiology of Staphylococcus epidermidis isolates from patients with catheter-related bacteremia and from healthy volunteers. J. Clin. Microbiol. 51, 1541–1547 (2013)

14. Chong J., Quach C., Blanchard A.C., Poliquin P.G., Golding G.R., Laferrière C., Lévesque S.: Molecular epidemiology of a vancomycin-intermediate heteroresistant Staphylococcus epidermidis outbreak in a neonatal intensive care unit. Antimicrob. Agents Chemother. 60, 5673–5681 (2016)

15. Chu V.H., Fowler V.G.Jr. i wsp.: Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis. Clin. Infect. Dis. 46, 232–242 (2008)

16. Conlan S., Segre J.A. i wsp.: Staphylococcus epidermidis pan-genome sequence analysis reveals diversity of skin commensal and hospital infection-associated isolates. Genome Biol. 13, DOI: 10.1186/gb-2012-13-7-r64 (2012)

17. Costa S.S., Viveiros M., Pomba C., Couto I.: Active antimicrobial efflux in Staphylococcus epidermidis: building up of resistance to fluoroquinolones and biocides in a major opportunistic pathogen. J. Antimicrob. Chemot. 73, 320–324 (2018)

18. De N., Godlove M.: Prevalence of S. aureus and S. epidermidis among patients with indwelling catheters and their antibiogram using some commonly used antibiotics. J. Am. Sci. 6, 515−520 (2010)

19. Denton C., Pappas E.G., Uricchio J.F., Goldberg H., Likoff W.: Bacterial endocarditis following cardiac surgery. Circulation, 15, 525–531 (1957)

20. Do G., Jarvis W.R. i wsp.: The emergence of decreased susceptibility to vancomycin in Staphylococcus epidermidis. Infect. Control. Hosp. Epidemiol. 20, 167–170 (1999)

21. Domingo P., Fontanet A.: Management of complications associated with totally implantable ports in patients with AIDS. AIDS Patient Care STDS, 15: 7–13 (2001)

22. Donker T., Wallinga J., Grundmann H.: Dispersal of antibiotic-resistant high risk clones by hospital networks: changing the patient direction can make all the difference. J. Hosp. Infect. 86, 34–41 (2014)

23. Du X., Zhu Y., Song Y., Li T., Luo T., Sun G., Yang C., Cao C., Lu Y., Li M.: Molecular analysis of Staphylococcus epidermidis strains isolated from community and hospital environments in China. Plos One, 8, e62742 (2013)

24. Duah M.: Daptomycin for methicillin-resistant Staphylococcus epidermidis native-valve endocarditis: a case report. Ann. Clin. Microbiol. Antimicrob. 9, DOI: 10.1186/1476-0711-9-9 (2010)

25. European Centre for Disease Prevention and Control (ECDC): Point prevalence survey of healthcare associated infections and antimicrobial use in European acute care hospitals 2011−2012. (2013) (26.02.2018)

26. Farrell D.J., Mendes R.E., Ross J.E., Jones R.N.: Linezolid surveillance program results for 2008 (LEADER Program for 2008). Diagn. Microbiol. Infect. Dis. 65, 392–403 (2009)

27. Franca A., Carvalhais V., Vilanova M., Pier G.B., Cerca N.: Characterization of an in vitro fed-batch model to obtain cells released from S. epidermidis biofilms. AMB Express, 6, DOI: 10.1186/s13568-016-0197-9 (2016)

28. Frebourg N.B., Lefebvre S., Baert S., Lemeland J.F.: PCR-based assay for discrimination between invasive and contaminating Staphylococcus epidermidis strains. J. Clin. Microbiol. 38, 877–880 (2000)

29. Galdbart J.O., Allignet J., Tung H.S., Ryde`n C., El Solh N.: Screening for Staphylococcus epidermidis markers discriminating between skin-flora strains and those responsible for infections of joint prostheses. J. Infecti. Dis. 182, 351–355 (2000)

30. Gatermann S.G., Koschinski T., Friedrich S.: Distribution and expression of macrolide resistance genes in coagulase-negative staphylococci. Clin. Microbiol. Infect. 13, 777–781 (2007)

31. Ghassemi A., Farhangi H., Badiee Z., Banihashem A., Mosaddegh M.R.: Evaluation of nosocomial infection in patients at hematology-oncology ward of Dr. Sheikh children’s hospital. Iran. J. Ped. Hematol. Oncol. 5, 179–185 (2015)

32. Gill S.R., Fraser C.M. i wsp.: Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J. Bacteriol. 187, 2426–2438 (2005)

33. Grice E.A., Segre J.A. i wsp.: Topographical and temporal diversity of the human skin microbiome. Science, 29, 1190–1192 (2009)

34. Hellmark B., Unemo M., Nilsdotter-Augustinsson A., Söderquist B.: Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections with special focus on rifampicin and variability of the rpoB gene. Clin. Microbiol. Infect. 15, 238–244 (2009)

35. Hidron A.I., Edwards J.R., Patel J., Horan T.C., Sievert D.M., Pollock D.A., Fridkin S.K.: Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect. Control Hosp. Epidemiol. 29, 996–1011 (2008)

36. Hira V., Sluijter M., Goessens W.H., Ott A., de Groot R., Hermans P.W., Kornelisse R.F.: Coagulase-negative staphylococcal skin carriage among neonatal intensive care unit personnel: from population to infection. J. Clin. Microbiol. 48, 3876–3881 (2010)

37. Hovelius B., Mardh P.A.: Staphylococcus saprophyticus as a common cause of urinary tract infections. Rev. Infect. Dis. 6, 328−337 (1984)

38. Hu H., Johani K., Gosbell I.B., Jacombs A.S., Almatroudi A., Whiteley G.S., Deva A.K., Jensen S., Vickery K.: Intensive care unit environmental surfaces are contaminated by multidrug-resistant bacteria in biofilms: combined results of conventional culture, pyrosequencing, scanning electron microscopy, and confocal laser microscopy. J. Hosp. Infect. 91, 35–44 (2015)

39. Hwang J.H., Choi C.W., Chang Y.S., Choe Y. H., Park W.S., Shin S.M., Lee M., Lee S.I.: The efficacy of clinical strategies to reduce nosocomial sepsis in extremely low birth weight infants. J. Korean Med. Sci. 20, 177–181 (2005)

40. International Working Group on the Classification of Staphylococcal Cassette Chromosome Elements (IWG-SCC): Classification of staphylococcal cassette chromosome mec (SCCmec): guidelines for reporting novel SCCmec elements. Antimicrob. Agents Chemother. 53, 4961–4967 (2009)

41. Kelly S., Collins J., Maguire M., Gowing C., Flanagan M., Donnelly M., Murphy P.G.: An outbreak of colonization with linezolid-resistant Staphylococcus epidermidis in an intensive therapy unit. J. Antimicrob. Chemother. 61, 901–907 (2008)

42. Kocianova S., Vuong C., Yao Y., Voyich J.M., Fischer E.R., DeLeo F.R., Otto M.: Key role of poly-gamma-DL-glutamic acid in immune evasion and virulence of Staphylococcus epidermidis. J. Clin. Invest. 115, 688–694 (2005)

43. Kozitskaya S., Cho S.H., Dietrich K., Marre R., Naber K., Ziebuhr W.: The bacterial insertion sequence element IS256 occurs preferentially in nosocomial Staphylococcus epidermidis isolates: association with biofilm formation and resistance to aminoglycosides. Infect. Immun. 72, 1210–1215 (2004)

44. Kübler A., Mayzner-Zawadzka E., Durek G., Gaszyński W., Nestorowicz A., Karpel E.: Prevalence and incidence of severe sepsis in intensive therapy units in Poland. Anest. Int. Ther. 39, 90–94 (2007)

45. Kurtz S.M., Lau E., Watson H., Schmier J.K., Parvizi J.: Economic burden of periprosthetic joint infection in the United States. J. Arthroplasty, 27, 61–65 (2012)

46. Lee J.Y.H., Monk I.R., Pidot S.J., Singh S., Chua K.Y.L., Seemann T., Stinear T.P., Howden B.P.: Functional analysis of the first complete genome sequence of a multidrug resistant sequence type 2 Staphylococcus epidermidis. Microb. Genom. 2(9): e000077 DOI:10.1099/mgen.0.000077 (2016)

47. Luk A., Kim M.L., Ross H.J., Rao V., David T.E., Butany J: Native and prosthetic valve infective endocarditis: clinicopathologic correlation and review of the literature. Malays. J. Pathol. 36, 71–81 (2014)

48. McCann M.T., Gilmore B.F., Gorman S.P.: Staphylococcus epidermidis device-related infections: pathogenesis and clinical management. J Pharm. Pharmacol. 60, 1551–1571 (2008)

49. McTaggart L.A., Rigby R.C., Elliott T.S.: The pathogenesis of urinary tract infections associated with Escherichia coli, Staphylococcus saprophyticus and S. epidermidis. J. Med. Microbiol. 32, 135–141 (1990)

50. Mendes R.E., Deshpande L.M., Costello A.J., Farrell D.J.: Molecular epidemiology of Staphylococcus epidermidis clinical isolates from U.S. hospitals. Antimicrob. Agents Chemother. 56, 4656–4661 (2012)

51. Mermel L.A., Allon M., Bouza E., Craven D.E., Flynn P., O’Grady N.P., Raad I.I., Rijnders B.J., Sherertz R.J., Warren D.K.: Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 49, 1–45 (2009)

52. Miller J.J., Scott I.U., Flynn H.W.J., Smiddy W.E., Newton J.: Acute-onset endophthalmitis after cataract surgery (2000–2004): incidence, clinical settings, and visual acuity outcomes after treatment. Am. J. Ophthalmol. 139, 983–987 (2005)

53. Miragaia M., Carriço J.A., Thomas J.C., Couto I., Enright M.C., de Lencastre H.: Comparison of molecular typing methods for characterization of Staphylococcus epidermidis: proposal for clone definition. J. Clin. Microbiol. 46, 118–129 (2008)

54. Miragaia M., Thomas J.C., Couto I., Enright M.C., de Lencastre H.: Inferring a population structure for Staphylococcus epidermidis from multilocus sequence typing data. J. Bacteriol. 189, 2540–2552 (2007)

55. Moloney T.P., Park J.: Microbiological isolates and antibiotic sensitivities in culture-proven endophthalmitis: a 15-year review. Br. J. Ophthalmol. 98, 1492–1497 (2014)

56. Monsen T., Karlsson C., Wiström J.: Spread of clones of multidrug-resistant, coagulase-negative staphylococci within a university hospital. Infect. Control Hosp. Epidemiol. 26, 76–80 (2005)

57. Montanaro L., Speziale P., Campoccia D., Ravaioli S., Cangini I., Pietrocola G., Giannini S., Arciola C.: Scenery of Staphylococcus implant infections in orthopedics. Future Microbiol. 6, 1329–1349 (2011)

58. Morris S., Gould K., Ferguson L.P.:. The use of daptomycin to treat methicillin-resistant Staphylococcus epidermidis bacteremia in a critically III child with renal failure. J. Pediatr. Pharmacol. Ther. 22, 300–303 (2017)

59. Najar-Peerayeh S., Moghadas A.J., Behmanesh M.: Antibiotic susceptibility and mecA frequency in Staphylococcus epidermidis, isolated from Intensive Care Unit patients. Jundishapur J. Microbiol. 7, e11188, DOI: 10.5812/jjm.11188 (2014)

60. Nikbakht M., Nahaei M.R., Akhi M.T., Asgharzadeh M., Nikvash S.: Molecular fingerprinting of meticillin-resistant Staphylococcus aureus strains isolated from patients and staff of two Iranian hospitals. J. Hosp. Infect. 69, 46–55 (2008)

61. NPOA – Narodowy Program Ochrony Antybiotyków.: Definicje zakażeń związanych z opieką zdrowotną (HAI) obowiązujące od 1 stycznia 2016 r. wg ECDC. (2016), (26.02.2018)

62. O’Callaghan R.J.: The pathogenesis of Staphylococcus aureus eye infections. Pathogens, 7, DOI: 10.3390/pathogens7010009 (2018)

63. Otto M.: Staphylococcus epidermidis – the ’accidental’ pathogen. Nat. Rev. Microbiol. 7, 555–567 (2009)

64. Parte A.C.: LPSN-list of prokaryotic names with standing in nomenclature. Nucleic Acids Res. 42, DOI: 10.1093/nar/gkt1111(2014)

65. Pien B.C., Sundaram P., Raoof N., Costa S.F., Mirrett S., Woods C.W., Reller L.B., Weinstein M.P.: The clinical and prognostic importance of positive blood cultures in adults. Am. J. Med. 123, 819–828 (2010)

66. Pinheiro L., Brito C.I., Pereira V.C., Oliveira A., Bartolomeu A.R., Camargo C.H.: Susceptibility profile of Staphylococcus epidermidis and Staphylococcus haemolyticus isolated from blood cultures to vancomycin and novel antimicrobial drugs over a period of 12 years. Microb. Drug Resist. 22, 283–293 (2016)

67. Pournaras S., Ntokou E., Zarkotou O., Ranellou K., Themeli-Digalaki K., Stathopoulos C., Tsakris A.: Linezolid dependence in Staphylococcus epidermidis bloodstream isolates. Emerg. Infect. Dis. 19, 129–132 (2013)

68. Qazi S.A., Stoll B.J.: Neonatal sepsis: a major global public health challenge. Pediatr. Infect. Dis. J. 28, DOI: 10.1097/INF.0b013e31819587a9 (2009)

69. Relhan N., Albini T., Pathengay A., Flynn H.W.: Bilateral endogenous endophthalmitis caused by vancomycin-resistant Staphylococcus epidermidis in a neonate. J. Ophthalmic Inflamm. Infect. 5, DOI: 10.1186/s12348-015-0039-y (2015)

70. Ribeiro M., Monteiro F.J., Ferraz M.P.: Infection of orthopedic implants with emphasis on bacterial adhesion process and techniques used in studying bacterial-material interactions. Biomatter. 2, 176–194 (2012)

71. Rolo J., de Lencastre H., Miragaia M.: Strategies of adaptation of Staphylococcus epidermidis to hospital and community: amplification and diversification of SCCmec. J. Antimicrob. Chemother. 67, 1333–1341 (2012)

72. Rosenthal V.D, Graves N. i wsp.: Time-dependent analysis of length of stay and mortality due to urinary tract infections in ten developing countries: INICC findings. J. Infect. 62, 136−141 (2011)

73. Rotger M., Trampuz A., Piper K.E., Steckelberg J.M., Patel R.: Phenotypic and genotypic mupirocin resistance among staphylococci causing prosthetic joint infection. J. Clin. Microbiol. 43, 4266–4268 (2005)

74. Rupp M.E., Archer G.L.: Coagulase-negative staphylococci: pathogens associated with medical progress. Clin. Infect. Dis. 19, 231–245 (1994)

75. Salih. L., Tevell S., Mansson E., Nilsdotter-Augustinsson A., Hellmark B., Soderquist B.: Staphylococcus epidermidis isolates from nares and prosthetic joint infections are mupirocin susceptible. J. Bone Joint Infect. 3, DOI: 10.7150/jbji.22459 (2018)

76. Siddiq M., Darouiche R.O.: New strategies to prevent catheter-associated urinary tract infections. Nat. Rev. Urol. 9, 305–314 (2012)

77. Sieradzki K., Villari P., Tomasz A.: Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin resistant clinical isolates of staphylococci. Antimicrob. Agents Chemother. 42, 100–107 (1998)

78. Söderquist B., Andersson M., Nilsson M., Nilsdotter-Augustinsson A., Persson L., Friberg O., Jacobsson S.: Staphylococcus epidermidis surface protein I (SesI): a marker of the invasive capacity of S. epidermidis? J. Med. Microbiol. 58, 1395–1397 (2009)

79. Taylor S.D., Palmer M.: The action mechanism of daptomycin. Bioorg. Med. Chem. 15, 6253–6268 (2016)

80. Thomas J.C., Vargas M.R., Miragaia M., Peacock S.J., Archer G.L., Enright M.C.: Improved multilocus sequence typing scheme for Staphylococcus epidermidis. J. Clin. Microbiol. 45, 616–619 (2007)

81. Thylefors J.D., Harbarth S., Pittet D.: Increasing bacteremia due to coagulase-negative staphylococci: fiction or reality? Infect. Control. Hosp. Epidemiol. 19, 581–589 (1998)

82. Tolo I., Thomas J.C., Fischer R.S.B., Brown E.L., Gray B.M., Robinson D.A.: Do Staphylococcus epidermidis genetic clusters predict isolation sources? J. Clin. Microbiol. 54, 1711–1719 (2016)

83. Trevino M., Martinez-Lamas L., Romero-Jung P.A., Giraldez J.M, Alvarez-Escuder J., Regueir B.J.: Endemic linezolid-resistant Staphylococcus epidermidis in a critical care unit. Eur. J. Clin. Microbiol. Infect. Dis. 28, 527–533 (2009)

84. Vasudevan R.: Urinary tract infection: an overview of the infection and the associated risk factors. J. Microbiol. Exp. 1, DOI: 10.15406/jmen.2014.01.00008 (2014)

85. von Eiff, C.; Reinert, R.R.; Kresken, M.; Brauers, J.; Hafner, D.: Nationwide German multicenter study on prevalence of antibiotic resistance in staphylococcal bloodstream isolates and comparative in vitro activities of quinupristin dalfopristin. J. Clin. Microbiol. 38, 2819–2823 (2000)

86. Widerström M., Wiström J., Edebro H., Marklund E., Backman M., Lindqvist P., Monsen T.: Colonization of patients, healthcare workers, and the environment with healthcare-associated Staphylococcus epidermidis genotypes in an intensive care unit: a prospective observational cohort study. BMC Infect. Dis. 16, DOI: 10.1186/s12879-016-2094-x (2016a)

87. Widerström M.: Significance of Staphylococcus epidermidis in health care-associated infections, from contaminant to clinically relevant pathogen: this is a wake-up call! J. Clin. Microbiol. 54, 1679–1681 (2016b)

88. Widerström M., McCullough C.A., Coombs G.W., Monsen T., Christiansen K.J.: A multidrug-resistant Staphylococcus epidermidis clone (ST2) is an ongoing cause of hospital-acquired infection in a Western Australian Hospital. J. Clin. Microbiol. 50, 2147–2151 (2012a)

89. Widerström M., Wiström J., Sjöstedt A., Monsen T.: Coagulase-negative staphylococci: update on the molecular epidemiology and clinical presentation, with a focus on Staphylococcus epidermidis and Staphylococcus saprophyticus. Eur. J. Clin. Microbiol. Infect. Dis. 31, 7–20 (2012b)

90. Widerstrom M., Monsen T., Karlsson C., Edebro H., Johansson A., Wistrom J.: Clonality among multidrug-resistant hospital-associated Staphylococcus epidermidis in Northern Europe. Scand. J. Infect. Dis. 41, 642–649 (2009)

91. Widerstrom M., Monsen T., Karlsson C., Wistrom J.: Molecular epidemiology of meticillin-resistant coagulase-negative staphylococci in a Swedish county hospital: evidence of intra- and interhospital clonal spread. J. Hosp. Infect. 64, 177–183 (2006)

92. Wu H., Moser C., Wang H.Z., Høiby N. Song Z.J.: Strategies for combating bacterial biofilm infections. Int. J. Oral Sci. 7, DOI: 10.1038/ijos.2014.65 (2014)

93. Yamada M., Yoshida J., Hatou S., Yoshida T., Minagawa Y.: Mutations in the quinolone resistance determining region in Staphylococcus epidermidis recovered from conjunctiva and their association with susceptibility to various fluoroquinolones. Br. J. Ophthalmol. 92, 848–851 (2008)

94. Yilmaz C, Colak M, Yilmaz B.C. i wsp.: Bacteriophage therapy in implant-related infections: an experimental study. J. Bone Joint Surg. Am. 95, 117–125 (2013)

95. Zhang Y.Q., Wen Y.M. i wsp.: Genome-based analysis of virulence genes in a non-biofilm-forming Staphylococcus epidermidis strain (ATCC 12228). Mol. Microbiol. 49, 1577–1593 (2003)

96. Ziebuhr W., Hennig S., Eckart M., Kranzler H., Batzilla C., Kozitskaya S.: Nosocomial infections by Staphylococcus epidermidis: how a commensal bacterium turns into a pathogen. Int. J. Antimicrob. Ag. 28, 14–20 (2006)

97. Ziebuhr W., Heilmann C., Götz F., Meyer P., Wilms K., Straube E., Hacker J.: Detection of the intercellular adhesion gene cluster (ica) and phase variation in Staphylococcus epidermidis blood culture strains and mucosal isolates. Infect. Immun. 65, 890–896 (1997)